Literature DB >> 10603216

Toxic shock syndrome in the United States: surveillance update, 1979 1996.

R A Hajjeh1, A Reingold, A Weil, K Shutt, A Schuchat, B A Perkins.   

Abstract

Menstrual toxic shock syndrome (TSS) emerged as a public health threat to women of reproductive age in 1979 80. We reviewed surveillance data for the period 1979 to 1996, when 5,296 cases were reported, and discuss changes in the epidemiologic features of TSS.

Entities:  

Mesh:

Year:  1999        PMID: 10603216      PMCID: PMC2640799          DOI: 10.3201/eid0506.990611

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  14 in total

Review 1.  Postoperative toxic shock syndrome.

Authors:  D Hughes; J Stapleton
Journal:  Iowa Med       Date:  1991-02

2.  Reduced incidence of menstrual toxic-shock syndrome--United States, 1980-1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-06-29       Impact factor: 17.586

3.  Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin.

Authors:  P M Schlievert
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

4.  Toxic shock syndrome in Utah: a case-control and surveillance study.

Authors:  R H Latham; M W Kehrberg; J A Jacobson; C B Smith
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

5.  Toxic shock syndrome surveillance in the United States, 1980 to 1981.

Authors:  A L Reingold; N T Hargrett; K N Shands; B B Dan; G P Schmid; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Active surveillance for toxic shock syndrome in the United States, 1986.

Authors:  S Gaventa; A L Reingold; A W Hightower; C V Broome; B Schwartz; C Hoppe; J Harwell; L K Lefkowitz; S Makintubee; D R Cundiff
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

7.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

8.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

Review 9.  Epidemiology of toxic shock syndrome in the United States: overview.

Authors:  C V Broome
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

10.  Trends in infectious disease hospitalizations in the United States, 1980-1994.

Authors:  L Simonsen; L A Conn; R W Pinner; S Teutsch
Journal:  Arch Intern Med       Date:  1998-09-28
View more
  47 in total

1.  Global repression of exotoxin synthesis by staphylococcal superantigens.

Authors:  Nikola Vojtov; Hope F Ross; Richard P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

2.  Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment.

Authors:  J M Langley; C M Soder; P M Schlievert; S Murray
Journal:  Can Fam Physician       Date:  2003-07       Impact factor: 3.275

3.  A fatal case of staphylococcal toxic shock syndrome.

Authors:  Partha Roy; A K Sahni; Anshu Kumar
Journal:  Med J Armed Forces India       Date:  2013-08-02

4.  Understanding toxic shock syndrome.

Authors:  Jason P Burnham; Marin H Kollef
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

5.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

6.  Lack of muco-cutaneous signs of toxic shock syndrome when T cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma.

Authors:  N S Kamel; M C Banks; A Dosik; D Ursea; A A Yarilina; D N Posnett
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Mary L Delaney; Paul A Modern; Andrea M Dubois; Wendy Wieland-Alter; Kimberly W Wissemann; John E Wild; Michaelle B Jones; Jon L Seymour; Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 8.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 9.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

10.  Evaluation of surveillance methods for staphylococcal toxic shock syndrome.

Authors:  Lindsey Lesher; Aaron Devries; Richard Danila; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.